Management of a 20-mm Inflammatory Colonic Polyp
For a 20-mm inflammatory polyp (pseudopolyp), medical therapy is the primary approach—do not attempt endoscopic resection unless there is diagnostic uncertainty about neoplasia. Inflammatory polyps are non-neoplastic lesions that arise from repeated inflammation and healing, and they typically do not require removal unless causing complications or when malignancy cannot be excluded 1.
Key Diagnostic Considerations
The critical first step is confirming this is truly an inflammatory polyp versus a neoplastic lesion:
- Obtain targeted biopsies to confirm histology and rule out dysplasia-associated lesion or mass (DALM), which represents an ongoing clinical challenge in inflammatory bowel disease 1
- Use image-enhanced endoscopy (chromoendoscopy or NBI) to assess pit patterns and distinguish inflammatory from neoplastic tissue
- Document the lesion thoroughly with photos and precise anatomic location
Management Algorithm
If Confirmed Inflammatory Polyp (Pseudopolyp):
Medical therapy is first-line:
- Optimize anti-inflammatory treatment for the underlying IBD
- Evidence shows giant pseudopolyps (>15 mm) can completely regress with medical therapy alone, particularly with biologics like infliximab 2
- Monitor with surveillance colonoscopy to assess response
Endoscopic resection is NOT routinely indicated because:
- Pseudopolyps are non-neoplastic and do not require removal for cancer prevention
- Severe fibrosis often prevents successful endoscopic resection 2
- Attempting resection may cause unnecessary complications
Consider endoscopic or surgical intervention only if:
- Size-related complications occur (bleeding, obstruction, intussusception) 1
- Diagnostic uncertainty persists despite biopsies
- Medical therapy fails and symptoms develop
If Neoplastic Features Cannot Be Excluded:
If biopsies show dysplasia or histology is uncertain, then treat as a neoplastic lesion:
- Refer to an advanced endoscopist experienced in complex polypectomy before considering surgery 3
- EMR is the preferred technique for 20-mm non-pedunculated lesions 3
- Use viscous injection solutions (hydroxyethyl starch, Eleview) for better lift 3
- Resect in the fewest pieces possible in a single session 3
- Consider prophylactic clip closure if in the right colon 3
Surveillance Strategy
For confirmed inflammatory polyps:
- Patients with pseudopolyps are at intermediate risk for colorectal cancer and require regular endoscopic monitoring 1
- Follow standard IBD surveillance protocols rather than post-polypectomy surveillance
If endoscopic resection is performed (for neoplastic lesions):
- First surveillance at 6 months to assess for recurrence and synchronous lesions 3
- Use enhanced imaging and targeted biopsies of the scar site 3
- If clear at 6 months, repeat at 1 year, then 3 years 3
Critical Pitfalls to Avoid
- Do not attempt piecemeal resection of inflammatory polyps—the fibrosis makes this technically difficult and unnecessary 2
- Do not use ablative techniques (APC, snare tip coagulation) on visible tissue, as this increases recurrence risk 3
- Avoid excessive biopsy sampling if referral is planned, as this promotes scarring 4
- Do not confuse post-inflammatory artifact with residual neoplasia—nodular elevation with normal pit pattern is common and benign 3
The fundamental distinction is that inflammatory polyps are managed medically, while neoplastic polyps ≥20 mm require expert endoscopic resection. When in doubt about the nature of the lesion, limited biopsies for histologic confirmation should guide the management pathway.